EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of connexin 43 in hyperoxia-induced bronchopulmonary dysplasia and associated pulmonary hypertension

Claire-Marie Pilard iD, Laure Gassiat, Guillaume Cardouat, Isabel Gauthereau, Paul Robillard, Eric Dumas-de-la-Roque, Fanny Sauvestre, Fanny Pelluard, Sophie Berenguer, Melie Sarreau, Loïc Sentilhes, Fréderic Coatleven und 5 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0356364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Claire-Marie Pilard und 16 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Bordeaux, INSERM, CRCTB, U 1045, Pessac, France. Hauptthemen laut MEDLINE: Connexin 43, Hyperoxia, Hypertension, Pulmonary, Bronchopulmonary Dysplasia. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature infants frequently require oxygen supplementation due to lung immaturity, exposing them to the risk of bronchopulmonary dysplasia (BPD), a chronic lung disease characterized by arrested alveolar growth and inflammation. Connexin 43-dependent gap junctions (Cx43-GJ) regulate intercellular communication during lung development and inflammatory responses, but their involvement in BPD remains incompletely defined. This study aimed to assess the contribution of Cx43-GJ in experimental BPD and to evaluate whether selective pharmacological inhibition of Cx43 modulates hyperoxia-induced lung injury and pulmonary hypertension. Newborn rats were exposed to normoxia or hyperoxia (90% O 2 ) for 14 days and treated daily with the Cx43-GJ inhibitor 43 Gap26 or vehicle. Human fetal pulmonary artery smooth muscle cells (HfPA-SMC) were exposed to 21% O 2 or 60% O 2 and treated with or without 43 Gap26 for 48 hours. Lung morphology, function, surfactant protein expression, extracellular matrix markers, macrophage phenotype, cytokine secretion, and oxidative stress markers were assessed. In vivo , 43 Gap26 reduced hyperoxia-induced Cx43 overexpression and partially improved alveolarization. However, 43 Gap26 failed to prevent alterations in lung function, decreased surfactant protein-B expression, extracellular matrix remodeling, macrophage M2 polarization, increased tissue inhibitor of metalloproteinase-1 secretion, pulmonary hypertension, or mortality. Inhibition of Cx43 was also associated with reduced markers of type II alveolar epithelial cell expression. In HfPA-SMC, 43 Gap26 did not modify hyperoxia-induced secretion of pro-inflammatory cytokines, despite increased Cx43 expression. Classical markers of oxidative damage were not significantly increased under our experimental conditions, although heme oxygenase-1 expression was elevated. Overall, pharmacological inhibition of Cx43 partially restored alveolar structure but did not prevent major pathological features of experimental BPD or pulmonary hypertension. These findings suggest that Cx43-GJ signaling is involved in the regulation of alveolar structure during hyperoxic lung injury, but its pharmacological inhibition alone is insufficient to prevent the complex structural and vascular alterations characteristic of experimental BPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Connexin 43HyperoxiaHypertension, PulmonaryBronchopulmonary DysplasiaAnimalsHumansRatsAnimals, NewbornMyocytes, Smooth MuscleOxidative StressPulmonary ArteryGap JunctionsLungPeptides

Substanzen

Connexin 43Gap 26 peptidePeptides

Autor:innen und Institutionen

  • Univ. Bordeaux, INSERM, CRCTB, U 1045, Pessac, France.
  • Bordeaux-Bagatelle Protestant Health Centre, Maternity Department, Talence, France.
  • CHU de Bordeaux, Neonatology Department, Bordeaux, France.
  • CHU de Bordeaux, Pathology Department, Bordeaux, France.
  • CHU de Bordeaux, Obstetrics and Gynecology Department, Bordeaux, France.
  • CHU de Bordeaux, Respiratory Function Testing Department, Bordeaux, France.

ORCID-Profile: Claire-Marie Pilard

Förderung

  • Fondation pour la Recherche Médicale

Zitieren

APA

Pilard, C. M., Gassiat, L., Cardouat, G., Gauthereau, I., Robillard, P., Dumas-de-la-Roque, E., Sauvestre, F., Pelluard, F., Berenguer, S., Sarreau, M., Sentilhes, L., Coatleven, F., Vincienne, M., Marthan, R., Berger, P., Freund-Michel, V., & Guibert, C. (2026). Role of connexin 43 in hyperoxia-induced bronchopulmonary dysplasia and associated pulmonary hypertension. PLOS One. https://doi.org/10.1371/journal.pone.0356364

Vancouver

Pilard CM, Gassiat L, Cardouat G, Gauthereau I, Robillard P, Dumas-de-la-Roque E, et al. Role of connexin 43 in hyperoxia-induced bronchopulmonary dysplasia and associated pulmonary hypertension. PLOS One. 2026. doi:10.1371/journal.pone.0356364

BibTeX
@article{Pilard2026,
  author = {Pilard, Claire-Marie and Gassiat, Laure and Cardouat, Guillaume and Gauthereau, Isabel and Robillard, Paul and Dumas-de-la-Roque, Eric and Sauvestre, Fanny and Pelluard, Fanny and Berenguer, Sophie and Sarreau, Melie and Sentilhes, Loïc and Coatleven, Fréderic and Vincienne, Marie and Marthan, Roger and Berger, Patrick and Freund-Michel, Véronique and Guibert, Christelle},
  title = {Role of connexin 43 in hyperoxia-induced bronchopulmonary dysplasia and associated pulmonary hypertension},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0356364}
}
Kostenlos starten →